PharMerica (PMC) Tops Q1 EPS by 3c; Reaffirms Outlook
Tweet Send to a Friend
PharMerica (NYSE: PMC) reported Q1 EPS of $0.30, $0.03 better than the analyst estimate of $0.27. Revenue for the quarter came in at $498.9 million versus the consensus estimate of $493.58 million.
PharMerica reaffirmed FY2012 guidance.
For earnings history and earnings-related data on PharMerica (PMC) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
PharMerica reaffirmed FY2012 guidance.
For earnings history and earnings-related data on PharMerica (PMC) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Dollar Tree, Inc. (DLTR) Tops Q1 EPS by 2c; Issues Muted Outlook
- Marvell Technology Group (MRVL) Tops Q1 EPS by 5c; Issues Solid Outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
